Aegerion Pharmaceuticals Company
Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.
Estimated Revenue:
$10M to $50M
Funding Status:
M&A
Employee Number:
101-250
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2005
Technology:
Others